Hi. Recently I'm dealing with TCGA microarray data. According to the description, the level 3 data has already been normalized. However, when I boxplot the expression matrix, it seems that many of the chips (which are all from one platform) are quite different in quantiles. My question is should I normalize and/or log2 transform them?
•
written
by
chenchen314159 •
Normalization happens at Level 2 as explained here. So Level 3 TCGA data should be post-normalization and in a format more suitable for making interpretations. But different tumor-specific working groups may do the job differently. GBM was one of the earliest TCGA projects where a lot of lessons were yet to be learned - like abandoning U133A for RNA-seq based expression data. ;)
In general, you should read the method's sections in the tumor-specific marker papers. For TCGA GBM, the supplement here explains the "Creation of a unified Expression Dataset", but it's not clear whether this needed to be done on top of the Level 3 data.
I see. Should I use RNAseq instead? But seems that RNAseq has fewer participants than microarray.
Yes, I would recommend RNA-seq RSEMs, but I'm fairly certain that RNA-seq was not done for TCGA GBM. There was a lot of work done in this manuscript to make the most of the microarray data.
Hi! I am actually looking at TCGA level3 RNASeqV2 data. My goal is to look at the DEGs (tumor vs. normal) and I'm looking at LUAD now.
I am using edgeR at the moment since the original rsem paper mentioned that those rsem can be processed by edgeR.
I was wondering if it makes sense to include all the tumor samples available, including those that don't have the matching normal samples from the same participant, and analyze for the DEGs? What kind of normalization method would be recommended if I do so? Or can I just use the edgeR default normalization?
I don't have a good answer for you. You should post a new question on Biostars. Do this in general, if your question is even slightly unrelated.
Hello! I have a similar question, are the normalized values of TCGA level3 RNAseqV2 data already normalized to the normal adjacent tissue or are they representing tumor tissue? The data I downloaded falls under the TN blue category meaning it's Tumor/Matched Normal. Also would the unit of measurement be Intensity/RPKM/FPKM or fold-change? Thanks for any help!
Hi nnabavi and welcome, an important point: this should be a new question, not an answer to a different question
Also, read up some info here
If still in doubt then post a new question by using the "moderate -> delete" links and creating a new question. this will allow the Biostar gurus to be able to help you much better :)
Log in to answer this question.
Level 3 microarray data should be normalized. Which microarray is this? Have you looked at whether these differences correlate to tumor type, or subtype? Depending on the platform, these might be real genome-wide effects.
It's U133A. They are all from GBM tumors (no control). For subtypes, this platform lacks this information in clinical data.